�ǿմ�ý

Adult Congenital Heart Disease Program

Helps pediatric patients make the transition to adult care. Offers patients guidance on how to manage their heart conditions through adult milestones including employment, pregnancy, and physical activity.

Aortopathy Program

Provides specialized evaluation and care for patients with abnormal aortas.

Cardiomyopathy Program

Cardiomyopathy is a disease of the heart muscle. There are several forms of cardiomyopathy.

In the Cardiomyopathy Clinic at Primary Children's Hospital and the Eccles Ambulatory Care Center, our team of cardiomyopathy and heart failure specialists see children with all forms of cardiomyopathy.

We also care for children who are at risk for developing cardiomyopathy due to:

• a family risk,
• other disorders, or
• a history of toxin exposures, such as chemotherapeutic agents.

We have a team of highly skilled nurse practitioners and a cardiovascular geneticist who works closely with the physicians to care for your children and explain the condition, symptoms, and risks of inheritance.

When needed we provide state of the art testing, such as:

• three-dimensional echocardiogram,
• exercise testing,
• cardiac catheterization, and
• cardiac MRI.

Most children will undergo an echocardiogram, ECG, and consultation with the genetics counselor at the initial visit. There are also ongoing research studies related to pediatric cardiomyopathy for which your child may be eligible.

Fetal Heart Program

Greatly improves the care of infants with congenital heart disease through early fetal detection, prenatal planning, and expedient management after birth.

Heart Transplant & Heart Failure Program

Established as the pediatric arm of the U.T.A.H. Cardiac Transplant Program, the Heart Center provides care for children with end-stage heart disease a second chance at life.

High Risk Program

Provides closer, more consistent care and follow-up for single ventricle patients during the period between Stage I and Stage II surgeries.

Pulmonary Vascular Disease Program

Accurately and safely identifies the cause and severity of pulmonary vascular disease and then provides every available option for treatment to improve patients’ quality and length of life.